Cancer progression is traditionally viewed as a sequential tumorigenic process. Tumor cells at the primary sites gradually acquire the capacity to invade and intravasate into the systemic circulation. These circulating tumor cells serve as conduits for the spread to distant organs. However, successful colonization at distant organs is dependent on acquisition of the ability of circulating tumor cells to leave circulation (by extravasation) and to adapt to the new microenvironment (Chambers et al., 2002) . Emerging evidence indicates that disseminated tumor cells are present in the circulation in large numbers even at early stages of cancer, long before metastatic growth at distant sites can be detected (Husemann et al., 2008) . One recent study has demonstrated that even apparently untransformed mammary epithelial cells can take residence at distant organs, such as the lung, for an extended period of time, and that later induction of transformation is sufficient to induce metastatic growth (Podsypanina et al., 2008) . In this issue, Massagué and colleagues (Kim et al., 2009 ) add another twist to our understanding of tumor progression, showing that the flow of circulating tumor cells is not a one-way street-circulating cancer cells can reinfiltrate tumors at their organs of origin to promote the growth of the primary tumors (Figure 1) .
The low rate of successful metastatic growth is at least in part due to ratelimiting steps involving acquisition of the ability to extravasate and to adapt to new microenvironments. Massagué and colleagues reasoned that circulating tumor cells should require little adaptation to survive and grow at tumors from their primary organs. To test this hypothesis, the authors set up a clever tumor-seeding assay based on tumor xenograft models in mice. By implanting differentially labeled tumor xenografts at distinct anatomical locations within the same mouse, they asked if tumor cells disseminated from one xenograft could home to the second xenograft over time. The authors found that metastatic tumor cells injected into the mammary fat pad, under the skin, or intravenously, or tumor cells shed from metastatic lesions, are readily detectable in a contralateral recipient xenograft after 2 months. This tumor self-seeding phenomenon is observed with tumor cells from breast, colon, and skin, suggesting that this is a general phenomenon in epithelial tumors.
Massagué and colleagues further show that recipient tumors are preferentially seeded by highly metastatic derivatives from the tumor cell lines tested. In addition, these "seeder" cells colonize only to pre-existing tumors, not to the intact or Cell 139, December 24, 2009 ©2009 Elsevier Inc. 1227 mock-inoculated mammary glands. Gene expression analysis of these metastatic seeder populations identified a profile characteristic of mammary metastatic cells in brain, bone, and lung, suggesting that the ability to self-seed is common for metastatic cells with diverse tropisms. Further studies with breast cancer and melanoma models demonstrate that the process involves chemoattraction mediated by tumor-derived cytokines interleukins 6 and 8 (IL-6 and IL-8) and infiltration of seeder cells through actions of matrix metalloproteinase 1 (MMP1) and the actin bundling protein Fascin-1.
These experiments highlight the distinct roles of donor and recipient tumor populations in orchestrating tumor selfseeding. The importance of IL-6 and IL-8 as chemoattractants that recruit seeder tumor cells raises several interesting questions. IL-6 plays diverse roles in tumor growth (Schafer and Brugge, 2007) and cell transformation (Iliopoulos et al., 2009) . Inflammatory cytokines are also implicated in the maintenance of vasculature integrity (Dittmar et al., 2008) and may play an additional role in facilitating extravasation of the seeder cells. Moreover, many studies have shown that various epithelial tumors or their stromal components express IL-6 and IL-8. The differential affinity of the circulating breast cancer and melanoma tumor cells in the study to be attracted to IL-6 and IL-8 suggests that the spectrum of cytokine receptor expression influences target site selection. The central roles of MMP1 and Fascin-1 in tumor infiltration during self-seeding are consistent with previous studies showing that the expression of these two proteins is associated with tumor relapse and metastasis (Bos et al., 2009) , highlighting the similarities between infiltration in self-seeding and metastasis at distant sites.
The intriguing observation of tumor selfseeding led the authors to investigate the role of this process in tumor progression at the organismal level. They compared the growth rates of control tumors and primary tumors seeded by the circulating cells after accounting for the addition of the seeder populations. They found that the seeded tumors have an accelerated growth rate, supporting a role of tumor self-seeding in promoting growth of the primary tumor. The authors also observe enhanced angiogenesis and stromal recruitment, including leukocytes, macrophages, neutrophils, and myeloid cells. In at least one model using a breast cancer cell line, this recruitment is mediated by the cytokine CXCL1 produced by the seeder cells. Together, these observations support the notion that tumor selfseeding could promote primary tumor growth, enhance angiogenesis, and recruit stromal components.
Tumor microenvironments support tumor growth and promote tumor progression. Several studies demonstrate that components in the tumor stroma, such as mesenchymal stem cells, tumorassociated fibroblasts, and myofibroblasts, nourish various steps of tumor progression (Husemann et al., 2008; Karnoub et al., 2007) . Another elegant study has shown that the presence of a distinct tumor could stimulate growth of separate tumors at anatomically distant sites by promoting incorporation of bone marrow cells to the distant tumors (McAllister et al., 2008) . The current study demonstrates yet another phenomenon by which tumor cells cooperate to promote tumor progression and highlights additional processes, beyond genetic and epigenetic alterations, that contribute to cellular heterogeneity within primary tumors.
The intriguing phenomenon of tumor self-seeding provides new insights into the dynamics of tumor progression. It also provokes many interesting questions; most importantly, does tumor self-seeding play a role in human cancer progression and how does this phenomenon influence pathologic outcome? Although the data in this study provide evidence that tumor self-seeding promotes primary tumor growth, how this process ultimately influences cancer progression and distant metastases remains to be established. It is tempting to speculate that self-seeding might occur not only at the primary tumor site, but also at distinct metastatic sites. Each site could serve as a nesting ground to generate tumor variants that repopulate other metastatic sites as well as the primary tumor, thus accelerating tumor progression. Elucidating the interplay between tumor self-seeding and other tumorigenic processes will be crucial to our understanding of tumor evolution. 
